Monday 6-9-2014 Cognizant Technology Solutions (CTSH) $CTSH

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Monday 6-9-2014 Cognizant Technology Solutions (CTSH) $CTSH opened at 49.74 hitting the high price of 50.31 and a day low of 49.67 with a total volume of 2,253,375. CTSH had a previous close of 49.83 and has been seeing an average volume of 3,132,909.

Overall Average: 40% Buy

Recent stock forum discussions about CTSH http://investorshangout.com/search?q=CTSH&...mp;yt0=Go!

Cognizant Technology Solutions Rises 1.69% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri Jun 06, 5:46PM CDT
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $49.06 to a high of $50.00. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $49.01 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

SmarTrend Watching for Potential Pullback in Shares of Cognizant Technology Solutions After 1.69% Gain
Comtex SmarTrend(R) - Fri Jun 06, 5:45PM CDT
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $49.06 to a high of $50.00. Yesterday, the shares gained 1.7%, which took the trading range above the 3-day high of $49.01 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Technology Stocks On The Rise With Help From 3 Stocks
at The Street - Fri Jun 06, 12:03PM CDT
TheStreet highlights 3 stocks pushing the technology sector higher today. (full story)

Three Stocks Able to Begin Dividend Payments for a Substantial Payoff
at The Street - Tue Jun 03, 9:46AM CDT
Some companies are perfectly positioned to pay dividends. These three are good investments on their own but don't be surprised if they declare a dividend in the near future. (full story)

Cognizant to Present at Bank of America Merrill Lynch 2014 Global Technology Conference
PR Newswire - Tue May 27, 4:25PM CDT
Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced that Karen McLoughlin, Chief Financial Officer, will present at the following investor conference: (full story)

Technical Coverage on IT Services Stocks -- Research on Infosys, Cognizant Technology Solutions, Automatic Data Processing, and ModusLink Global Solutions
PR Newswire - Tue May 27, 6:10AM CDT
The trading session on Friday, May 23, 2014 ended on a higher note as the Dow Jones Industrial Average finished at 16,606.27, up 0.38% and the NASDAQ Composite closed at 4,185.81, up 0.76%. The S&P 500 finished the day 0.42% higher at 1,900.53. During the session, eight out of ten sectors finished on a positive note. The S&P 500 Information Technology Sector Index ended the day at 610.00, up 0.97%, with the index advancing 4.10% in the last one month. Investor-Edge has initiated coverage on the following equities: Infosys Ltd (NYSE: INFY), Cognizant Technology Solutions Corporation (NASDAQ: CTSH), Automatic Data Processing Inc. (NASDAQ: ADP) and ModusLink Global Solutions Inc. (NASDAQ: MLNK). Free technical research on INFY, CTSH, ADP and MLNK can be downloaded upon signing up at: (full story)

The Top 25 of the Value Investor 500
Dan Dzombak, The Motley Fool - Motley Fool - Sat May 24, 8:03AM CDT
Every year Fortune publishes its highly regarded Fortune 500, a list of the top 500 companies in the U.S. by revenue. While revenue is important, it should never be the gauge for the success of a business or management team. For an investor, the... (full story)

2014 Value Investor 500: The Full List
Dan Dzombak, The Motley Fool - Motley Fool - Sat May 24, 8:01AM CDT
The Value Investor 500 is my attempt to highlight the top 500 publicly traded companies in the U.S. To construct a quality-based list of the top 500 companies in the U.S., I focused on what's really important for investors to pay attention to: ... (full story)

Cognizant Technology Solutions Rises 2.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Fri May 23, 4:01PM CDT
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $47.53 to a high of $48.67. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $47.99 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

SmarTrend Watching for Potential Pullback in Shares of Cognizant Technology Solutions After 2.04% Gain
Comtex SmarTrend(R) - Fri May 23, 4:01PM CDT
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $47.53 to a high of $48.67. Yesterday, the shares gained 2.0%, which took the trading range above the 3-day high of $47.99 on volume of 3.2 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. (full story)

Cognizant to Present at Investor Conferences
PR Newswire - Fri May 23, 9:24AM CDT
Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced that senior management will present at the following investor conferences: (full story)

Cognizant Technology Solutions Earnings Hindsight: Up 0.3% in Last 12 Days (CTSH)
Comtex SmarTrend(R) - Mon May 19, 12:11PM CDT
When Cognizant Technology Solutions (NASDAQ:CTSH) reported earnings 12 days ago on May 7th, 2014, analysts, on average, expected the company to report earnings of $0.59 on sales of $2.4 billion. Cognizant Technology Solutions actually reported earnings of $0.62 per share on sales of $2.4 billion, beating EPS estimates by $0.03 and missing revenue estimates by $4.5 million. Since the company's report, shares of Cognizant Technology Solutions have risen from $47.02 to $47.18, representing a gain of 0.3% in the past 12 days. (full story)

Look for Shares of Cognizant Technology Solutions to Potentially Rebound after Yesterday's 2.90% Sell Off
Comtex SmarTrend(R) - Thu May 15, 4:43PM CDT
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $46.92 to a high of $48.73. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $48.06 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Watch for Cognizant Technology Solutions to Potentially Rebound After Falling 2.90% Yesterday
Comtex SmarTrend(R) - Thu May 15, 4:43PM CDT
Cognizant Technology Solutions (NASDAQ:CTSH) traded in a range yesterday that spanned from a low of $46.92 to a high of $48.73. Yesterday, the shares fell 2.9%, which took the trading range below the 3-day low of $48.06 on volume of 4.9 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. (full story)

Cognizant to Present at the J.P. Morgan Technology, Media and Telecom Conference
PR Newswire - Tue May 13, 7:35AM CDT
Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced that Gordon Coburn, President, will present at the following investor conference: (full story)

Strategic Agreements, Grants, Financial Results, and New Service Launches - Analyst Notes on AOL, EMC, Cognizant, Trimble and Vodafone
PR Newswire - Mon May 12, 6:00AM CDT
Today, Analysts Review released its analysts' notes regarding AOL, Inc. (NYSE: AOL), EMC Corporation (NYSE: EMC), Cognizant Technology Solutions Corporation (NASDAQ: CTSH), Trimble Navigation Limited (NASDAQ: TRMB) and Vodafone Group plc (NASDAQ: VOD). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2323-100free. (full story)

Cognizant to Present at BMO Capital Markets IT Services Day
PR Newswire - Thu May 08, 3:37PM CDT
Cognizant (NASDAQ: CTSH), a leading provider of information technology, consulting, and business process outsourcing services, today announced that Karen McLoughlin, Chief Financial Officer, will present at the following investor conference: (full story)

Cognizant Technology Solutions (CTSH) Crosses Pivot Point Resistance at $47.76
Comtex SmarTrend(R) - Thu May 08, 1:14PM CDT
Shares of Cognizant Technology Solutions (NASDAQ:CTSH) have bullishly opened above the pivot of $46.74 today and have reached the first resistance level of $47.76. Investors may be interested in a cross of the next upside pivot targets of $48.49 and $50.24. (full story)

Stay Away From Infosys
at The Street - Thu May 08, 8:40AM CDT
Infosys's recent earnings beat was largely due to a favorable exchange rate. The company could struggle in the future with strengthening rupee and a high retention rate, despite the positive outlook for the industry. (full story)

Cognizant Tech's Q1 mixed
at Investor's Business Daily - Wed May 07, 6:00PM CDT
The IT consulting and outsourcing company said EPS jumped 21.5% to 62 cents, beating views by 7 cents. Revenue climbed 19.9% to $2.42 bil, roughly in line with views, as issues with health care clients and the Affordable Care Act hurt growth. For Q2,... (full story)

Cognizant Technology Solutions (CTSH) Stock Research Links

CTSH Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Ivonescimab Promises New Hope for Advanced BTC Patients

Updated Category News Views 313

Shifting the Paradigm in Biliary Tract Cancer Treatment Here's the scoop from the bustling world of oncology: the trial of Ivonescimab plus chemotherapy is stirring waves among experts in advanced biliary tract cancer (BTC). Contrary to the usual drowsy mornings with coffee and market pages, this data from Hong Kong wasn't about Wall Street this time. This trial might...

Continue Reading
Monster Energy Unleashes Gaming Frenzy at Cosm L.A. Event

Updated Category News Views 193

Where Energy Drinks and Digital Reality Collide Monster Energy sure knows how to throw a party, especially when it hinges on something as electrifying as Call of Duty: Modern Warfare 4. Imagine this: Cosm Los Angeles is decked out with a massive 87-foot LED dome, and every gamer, celeb, and influencer ready to dive right in. You can't make this stuff up. They've mashed...

Continue Reading
Firefox Champions Privacy with Iconic Internet Campaign

Updated Category News Views 128

Rekindling the Internet’s Golden Days with Firefox There’s something almost poetic about Firefox hustling to win back its old users by launching a campaign with legendary internet icons. The backdrop? A digital landscape where privacy feels about as common as a unicorn sighting. Mozilla's pulling a major nostalgia card, and I'm here for it—sort of like how vinyl...

Continue Reading
DigitalXForce Shakes Up GRC: AI-Infused X-ROC Launch

Updated Category News Views 130

Turning Risk Management on Its Head Well, here's a company not just tinkering around the edges but flipping the script on Governance, Risk, and Compliance (GRC) with their latest rollout: DigitalXForce and its X-ROC. Yeah, it's yet another acronym to juggle, but don't roll your eyes just yet. This AI-driven beast isn't about occasional boardroom reports. No sir, it's a...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 258

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 224

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 332

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 134

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Sac-TMT's Phase III Success Shifts Lung Cancer Paradigm

Updated Category News Views 541

A New Era in Lung Cancer Treatment? Sac-TMT, the novel antibody-drug conjugate (ADC), just might be shaking up the non-small cell lung cancer (NSCLC) treatment landscape, and boy, is it making waves. Just when you think you’ve seen it all, here comes sacituzumab tirumotecan (sac-TMT), offering a glimmer of hope for patients whose treatment options have dwindled after...

Continue Reading
Tennessee's Bold Lung Cancer Trial Signals Innovation

Updated Category News Views 161

The Heartbeat of Innovation in Cancer Therapy Who would've thought Tennessee would be at the forefront of a global push against lung cancer? Sure, there's Nashville's music scene, but it's the researchers at Tennessee Oncology who are grooving to a different beat—one that might just set the rhythm for advanced cancer therapies worldwide. Yeah, it's a trial, but not just...

Continue Reading

Top 5 Most Recently Viewed Articles

Phreesia Announces Q3 Fiscal Year 2025 Financial Results

Updated Category News Views 71

Phreesia to Release Fiscal Q3 2025 Results Soon Phreesia, Inc. (NYSE: PHR) has great news for its stakeholders! The company revealed plans to announce its financial results for the third quarter of fiscal year 2025 right after market closing on a Monday in December. During this quarter, the firm experienced substantial growth and is eager to share the details with the...

Continue Reading
Innovative Water Bowl Design Enhances Pet Hydration Experience

Updated Category News Views 374

Revolutionary Pet Water Bowl Crafted for Optimal Hydration Every pet owner knows the importance of keeping their furry friends hydrated, especially during hot days. A new invention promises to enhance the experience for pets and their owners alike. This innovative water bowl, known as the THERMA DRINK, is designed with features that cater directly to pet needs. The idea...

Continue Reading
HPH's Leadership Changes Signify Strategic Direction Ahead

Updated Category News Views 177

Leadership Transitions at HPH Highest Performances Holdings Inc. (NASDAQ: HPH) has recently seen a notable change in its Board of Directors. The company announced that Mr. Peh Chin Hua's tenure as Director has come to an end, effective immediately. This decision is part of a broader strategy aimed at strengthening the Board's overall composition and capabilities. Current...

Continue Reading
Apranga Group Reports Growth in Retail Turnover for 2025

Updated Category News Views 132

Apranga Group Retail Performance Overview for 2025 Apranga Group, a major player in the retail sector, has announced its impressive financial performance for the first six months of 2025, demonstrating notable growth compared to the prior year. The company's retail turnover reached a commendable EUR 166.1 million, reflecting a 2.8% increase from the same period in 2024....

Continue Reading
IMUNON Unveils Promising New Vaccine Data for COVID-19

Updated Category News Views 154

New Vaccine Insights from IMUNON's Phase 1 Clinical Trial The innovative PlaCCine technology platform developed by IMUNON, Inc. (NASDAQ: IMNN) promises remarkable durability and advantages over traditional mRNA vaccines, particularly in the struggle against COVID-19. Robust Results from IMNN-101 Vaccine Trials In an encouraging announcement, IMUNON shared pivotal data...

Continue Reading